Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...
BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1457 | 30.2910602911 | 0.481 | 0.926 | 0.48 | 1087237 | 0.75772694 | CS |
| 4 | 0.0117 | 1.90243902439 | 0.615 | 0.926 | 0.38 | 339971 | 0.7016984 | CS |
| 12 | 0.2687 | 75.0558659218 | 0.358 | 0.926 | 0.31 | 477048 | 0.61177713 | CS |
| 26 | -1.7033 | -73.1030042918 | 2.33 | 2.33 | 0.185 | 520028 | 0.48930049 | CS |
| 52 | -2.3333 | -78.8277027027 | 2.96 | 3.16 | 0.185 | 461041 | 0.5001947 | CS |
| 156 | -2.3333 | -78.8277027027 | 2.96 | 3.16 | 0.185 | 461041 | 0.5001947 | CS |
| 260 | -2.3333 | -78.8277027027 | 2.96 | 3.16 | 0.185 | 461041 | 0.5001947 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
